Related Experiment Video
Updated: May 14, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
FHIT suppresses cervical squamous cell carcinoma progression by negatively regulating UBE2I-mediated SUMO
Shunjie Zheng1, Fulei Shao2, Liujuan Shao1
1Department of Gynecology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, Zhejiang, China.
Purpose:
FHIT functions as a tumor suppressor frequently silenced by promoter hypermethylation in multiple cancers, including cervical cancer. This study elucidates its role in progression and immunoregulation of cervical squamous cell carcinoma (CSCC) and identifies downstream molecular mechanisms.
Methods:
GEO datasets containing CSCC tissue data were mined to screen aberrantly expressed genes. TCGA database was queried to analyze FHIT expression and DNA methylation patterns between cervical cancer and normal tissues; findings were validated by RT-qPCR, MSP-PCR and Western blot in CSCC versus normal cell lines. Gain- and loss-of-function experiments overexpressing or knocking down FHIT investigated its impact on proliferation, metastasis and macrophage modulation. Potential upstream regulators and pathway involvement were further explored.
Results:
FHIT was predicted to be hypermethylated and downregulated in CSCC. Overexpression of FHIT in CSCC cells significantly suppressed cell proliferation, migration, and invasion. Furthermore, when co-cultured with macrophages, FHIT-overexpressing CSCC cells promoted the polarization of macrophages toward the anti-tumor M1 phenotype. Mechanistically, FHIT was found to bind to UBE2I protein and downregulate its expression. Overexpression of UBE2I reversed the tumor-suppressive effects of FHIT. UBE2I was shown to mediate SUMO modification at lysine residue K1607 of NOTCH1. Mutation at the K1607 site of NOTCH1 abolished the oncogenic effects induced by UBE2I in CSCC.
Conclusions:
In summary, this study focuses on the antitumor role and molecular mechanisms of FHIT in CSCC. The FHIT/UBE2I/NOTCH1 regulatory axis may serve as a potential therapeutic target for CSCC through immunomodulatory strategies.
Insights
The fragile histidine triad (FHIT) gene suppresses tumors in cervical squamous cell carcinoma (CSCC). Restoring FHIT inhibits cancer growth and promotes anti-tumor immune responses by targeting the UBE2I/NOTCH1 pathway.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Fragile histidine triad (FHIT) acts as a tumor suppressor, often silenced by promoter hypermethylation in various cancers.
- FHIT silencing is prevalent in cervical squamous cell carcinoma (CSCC), suggesting a role in its pathogenesis.
Purpose of the Study:
- To investigate the role of FHIT in CSCC progression and immunoregulation.
- To identify the downstream molecular mechanisms underlying FHIT's function in CSCC.
Main Methods:
- Analysis of GEO and TCGA datasets for FHIT expression and methylation in CSCC.
- Validation using RT-qPCR, MSP-PCR, and Western blot in CSCC cell lines.
- Gain- and loss-of-function studies to assess FHIT's impact on proliferation, metastasis, and macrophage polarization.
Main Results:
- FHIT was found to be hypermethylated and downregulated in CSCC.
- FHIT overexpression suppressed CSCC cell proliferation, migration, and invasion.
- FHIT-overexpressing CSCC cells enhanced M1 macrophage polarization.
- FHIT targets UBE2I, which mediates SUMO modification of NOTCH1 at K1607, influencing oncogenesis.
Conclusions:
- FHIT exhibits antitumor properties in CSCC by inhibiting proliferation and metastasis.
- The FHIT/UBE2I/NOTCH1 axis plays a crucial role in CSCC development and immunoregulation.
- Targeting the FHIT/UBE2I/NOTCH1 pathway offers a potential immunomodulatory therapeutic strategy for CSCC.
Related Concept Videos
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

